Healthy Reiners Need Healthy Joints – Adequan® Renews Partnership as Official Joint Therapy of NRHA

For Immediate Release – April 24, 2019 – Oklahoma City, Oklahoma. – American Regent Animal Health, manufacturer of Adequan® i.m. (polysulfated glycosaminoglycan), recently announced their continued partnership with the National Reining Horse Association (NRHA). Adequan® i.m. not only serves as the official joint therapy of NRHA membership but also enhances the grassroots of reining as an official NRHA Affiliate Sponsor.

In addition to American Regent Animal Health’s official partnership, they serve as title sponsor of NRHA’s Adequan® North American Affiliate Championship Show (NAAC), an affiliate championship program that assists in the development of reining. American Regent Animal Health provides additional awards to the NAAC by sponsoring the Adequan® 500. This program rewards exhibitors by offering an additional $500 cash prize to the winner of each NAAC class who is a registrant of the Adequan® 500.

“It is an honor to continue our partnership with NRHA,” said Allyn Mann, Director of Strategic Partnerships for American Regent Animal Health. “We are committed to making a difference in the equine community by supporting organizations like NRHA that share our passion for the horse and advancing equestrian sport.”

American Regent Animal Health’s support helps NRHA exhibitors stay successful in the show pen by maintaining the health and soundness of their horses’ joints. Adequan® i.m. is indicated for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses. As a veterinarian-trusted name in the fight against equine degenerative joint disease, Adequan® i.m. is the only FDA-approved polysulfated glycosaminoglycan which has been proven to help improve joint function by reversing the disease cycle, repairing cartilage, restoring joint lubrication and reducing inflammation. Ask your veterinarian if Adequan® i.m. is the right choice for your horse.

“The NRHA partnership with Adequan® goes well beyond the show pen and reaches the heart of reining,” said Sammi Miller, NRHA Senior Director of Corporate Relations & Communications. “The support given through American Regent Animal Health for NRHA programs helps continue the growth of our sport. NRHA is better because of their support and we are excited about continuing a successful relationship with American Regent Animal Health!”

Make plans to support American Regent Animal Health’s partnership with NRHA by coming to Oklahoma City for the 2019 NRHA Futurity & Adequan® North American Affiliate Championship Show November 28–December 7. Visit NRHA.com for more information about this event and American Regent Animal Health’s continued support of the reining industry.

Adequan® i.m. Brand of Polysulfated Glycosaminoglycan (PSGAG)

IMPORTANT SAFETY INFORMATION

There are no known contraindications to the use of intramuscular Polysulfated Glycosaminoglycan. Studies have not been conducted to establish safety in breeding horses. WARNING: Do not use in horses intended for human consumption. Not for use in humans. Keep this and all medications out of the reach of children. CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For more information and Full Prescribing Information, visit www.adequan.com.

About American Regent Animal Health

American Regent Animal Health, formerly known as Luitpold Animal Health, is a division of American Regent, Inc. American Regent Animal Health is committed to advancing animal health with proven FDA-approved products like Adequan®. The company’s portfolio is anchored by the only FDA-approved polysulfated glycosaminoglycan products for horses and dogs, which have been relied on for nearly three decades by veterinarians. American Regent, Inc., a Daiichi Sankyo Group Company, manufactures and distributes human and veterinary pharmaceutical products and is committed to providing the ever-changing U.S. healthcare marketplace with a growing and diversified portfolio under the American Regent brand. For more information on American Regent Animal Health, visit ARAnimalHealth.com or call 800-458-0163.